CisplatinNasopharyngeal NeoplasmsRadiation DosageRadiation, IonizingRadiation InjuriesDose-Response Relationship, RadiationRadiation ToleranceRadiationRadiation ProtectionRadiation MonitoringAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsNeoplasmsCombined Modality TherapyPancreatic NeoplasmsRadiation OncologyNeoplasms, Radiation-InducedLung NeoplasmsOvarian NeoplasmsPlatinumRadiotherapyCosmic RadiationRadiation Injuries, ExperimentalHead and Neck NeoplasmsRadiotherapy DosageGamma RaysRadiation PneumonitisTreatment OutcomeNeoplasms, Cystic, Mucinous, and SerousDrug Resistance, NeoplasmNeoplasm StagingSkin NeoplasmsRadiation-Sensitizing AgentsBackground RadiationCarcinoma, Squamous CellDrug Administration ScheduleCell Line, TumorEtoposideUltraviolet RaysTesticular NeoplasmsDNA DamageFluorouracilRadiometryAdenocarcinomaNeoplasm Recurrence, LocalDeoxycytidineNeoplasms, Second PrimaryVinblastineSurvival AnalysisNeoplasms, Multiple PrimaryRadiation EffectsRadiation-Protective AgentsApoptosisPaclitaxelDNA, NeoplasmDNA AdductsDose FractionationCell SurvivalSurvival RateLiver NeoplasmsKidney NeoplasmsNeoplasms, Germ Cell and EmbryonalDNA RepairCarboplatinDisease-Free SurvivalCarcinoma, Non-Small-Cell LungTumor Cells, CulturedDoxorubicinThyroid NeoplasmsStomach NeoplasmsTime FactorsRadiotherapy, AdjuvantIfosfamideDose-Response Relationship, DrugCarcinomaAdenocarcinoma, MucinousDrug Screening Assays, AntitumorAcute Radiation SyndromeVomitingRadiotherapy, ConformalBone NeoplasmsNeoplasms, ExperimentalImmunohistochemistryRetrospective StudiesTomography, X-Ray ComputedBreast NeoplasmsX-RaysBrachytherapyInfusions, IntravenousPleural NeoplasmsNeoplasm ProteinsCobalt RadioisotopesMyeloproliferative DisordersDrug SynergismEsophageal NeoplasmsTaxoidsNose NeoplasmsNeoplasm MetastasisRadioactive Hazard ReleaseRadiotherapy, Intensity-Modulated